M&G PLC Lowers Position in Kenvue Inc. $KVUE

M&G PLC trimmed its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 1.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,030,140 shares of the company’s stock after selling 143,225 shares during the period. M&G PLC owned about 0.42% of Kenvue worth $128,482,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of KVUE. Salomon & Ludwin LLC purchased a new position in Kenvue during the third quarter valued at approximately $25,000. NBT Bank N A NY increased its holdings in shares of Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after acquiring an additional 1,006 shares during the period. Cornerstone Planning Group LLC raised its position in shares of Kenvue by 705.2% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after acquiring an additional 1,361 shares in the last quarter. Golden State Wealth Management LLC lifted its stake in shares of Kenvue by 150.1% during the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after purchasing an additional 1,190 shares during the last quarter. Finally, Trust Co. of Vermont boosted its position in Kenvue by 50.9% during the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after purchasing an additional 804 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

KVUE has been the subject of a number of recent research reports. Johnson Rice reiterated a “neutral” rating on shares of Kenvue in a report on Tuesday, October 28th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. Zacks Research upgraded shares of Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Edward Jones downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 3rd. Finally, Barclays lifted their price target on shares of Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Four research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $19.46.

Kenvue Stock Up 0.8%

KVUE stock opened at $18.70 on Monday. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17. The stock has a market capitalization of $35.82 billion, a PE ratio of 24.93 and a beta of 0.59. The firm has a 50 day moving average of $17.38 and a 200 day moving average of $17.70.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th will be issued a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.4%. Kenvue’s payout ratio is 110.67%.

Insider Activity

In other Kenvue news, Director Jeffrey C. Smith purchased 3,200,000 shares of Kenvue stock in a transaction on Friday, December 12th. The stock was bought at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the transaction, the director owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This represents a 13.27% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.17% of the stock is currently owned by insiders.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.